Anzeige
Mehr »
Login
Mittwoch, 28.02.2024 Börsentäglich über 12.000 News von 684 internationalen Medien
Feuerwerk fürs Depot: Rohstoff-Geheimtipp! Startet JETZT der Kursturbo?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EFB5 | ISIN: CH1251125998 | Ticker-Symbol: V6M
Berlin
28.06.19
20:00 Uhr
0,000 Euro
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RELIEF THERAPEUTICS HOLDING AG Chart 1 Jahr
5-Tage-Chart
RELIEF THERAPEUTICS HOLDING AG 5-Tage-Chart

Aktuelle News zur RELIEF THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06:49Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Renews CHF 50 million Share Subscription Facility320Relief Therapeutics Holding SA / Key word(s): Financing Relief Therapeutics Renews CHF 50 million Share Subscription Facility 28-Feb-2024 / 06:45 CET/CEST Release of an ad hoc announcement...
► Artikel lesen
05.12.23Relief Therapeutics Holding SA - 6-K, Report of foreign issuer28
05.12.23Relief Therapeutics will sich künftig auf Forschung & Entwicklung konzentrieren 501Das Biotechunternehmen will sich künftig auf F&E konzentrieren. Dazu sollen die Produkte im kommerziellen Stadium schrittweise auf ein Partnerschaftsmodell umgestellt werden.Genf - Das Biotechunternehmen...
► Artikel lesen
05.12.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth1.305Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth 05-Dec-2023...
► Artikel lesen
22.11.23Relief Therapeutics Holding SA - 6-K, Report of foreign issuer12
22.11.23Relief Therapeutics announces CEO transition3
22.11.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces CEO Transition1.296Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Announces CEO Transition 22-Nov-2023 / 08:40 CET/CEST Release of an ad hoc announcement pursuant to Art. 53...
► Artikel lesen
10.10.23Relief Therapeutics Holding SA - 6-K, Report of foreign issuer12
10.10.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone1.275Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company...
► Artikel lesen
15.09.23Relief Therapeutics Holding SA - 6-K, Report of foreign issuer13
15.09.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update1.711Relief Therapeutics Holding SA / Key word(s): Half Year Results Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update 15-Sep-2023 / 07:00 CET/CEST Release...
► Artikel lesen
01.09.23Relief Therapeutics Holding SA: Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference571Relief Therapeutics Holding SA / Key word(s): Conference Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference 01.09.2023...
► Artikel lesen
30.08.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA (ACER-001) with Acer Therapeutics2.279Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA (ACER-001) with Acer Therapeutics...
► Artikel lesen
19.07.23Relief Therapeutics Holding SA: Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health1.047Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S....
► Artikel lesen
23.06.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East2.163Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement...
► Artikel lesen
23.06.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Holding SA Announces Closing of CHF 5 Million Private Placement1.553Relief Therapeutics Holding SA / Key word(s): Financing/Private Equity RELIEF THERAPEUTICS Holding SA Announces Closing of CHF 5 Million Private Placement 23-Jun-2023 / 07:00 CET/CEST Release...
► Artikel lesen
20.06.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Holding SA Announces Results of Annual General Meeting of Shareholders1.429Relief Therapeutics Holding SA / Key word(s): AGMEGM RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of Shareholders 20-Jun-2023 / 10:57 CET/CEST Release of an ad hoc...
► Artikel lesen
16.06.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Holding SA Announces CHF 5 Million Private Placement2.160Relief Therapeutics Holding SA / Key word(s): Financing/Private Equity RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement 16-Jun-2023 / 07:00 CET/CEST Release of an ad hoc...
► Artikel lesen
29.05.23Brandessence Market Research and Consulting Private Limited: Pain Relief Therapeutics Market to Grow Significantly by 2029- Brandessence Market Research643LONDON, May 29, 2023 /PRNewswire/ -- Pains or aches can be a resultant of injuries, diseases, muscle or bone related issues, among others. Frequent aches disrupt our quality of life and prevents...
► Artikel lesen
26.05.23Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Holding SA Announces Notice of Annual General Meeting of Shareholders1.707Relief Therapeutics Holding SA / Key word(s): AGMEGM RELIEF THERAPEUTICS Holding SA Announces Notice of Annual General Meeting of Shareholders 26-May-2023 / 07:00 CET/CEST Release of an...
► Artikel lesen
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1